Key Points The option-exercise sale represented a notable amount of Shah's overall holdings. Nevertheless, the executive’s remaining stake—about 146,000 shares—still represents meaningful exposure. For long-term investors, Amneal’s growing revenue and upgraded guidance might help offset the headline impact of insider sales. These 10 stocks could mint the next wave of millionaires › Nikita Shah, the executive vice president of Amneal Pharmaceuticals (NASDAQ:AMRX), exercised 131,856 stock options a ...